MPM
TEVA icon

Meritage Portfolio Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Meritage Portfolio Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-78,470
Closed -$2.61M – 217
2017
Q2 		$2.61M Buy
+78,470
New +$2.43M 0.27% 145
2016
Q4 		– Sell
-101,262
Closed -$4.66M – 200
2016
Q3 		$4.66M Sell
101,262
-3,164
-3% -$165K 0.51% 101
2016
Q2 		$5.25M Sell
104,426
-1,335
-1% -$71.1K 0.59% 66
2016
Q1 		$5.66M Sell
105,761
-3,495
-3% -$205K 0.64% 55
2015
Q4 		$7.17M Sell
109,256
-1,220
-1% -$75.4K 0.81% 28
2015
Q3 		$6.24M Buy
110,476
+1,153
+1% +$74.8K 0.72% 38
2015
Q2 		$6.46M Sell
109,323
-1,155
-1% -$71.3K 0.68% 36
2015
Q1 		$6.88M Buy
110,478
+14
+0% +$814 0.69% 33
2014
Q4 		$6.35M Sell
110,464
-1,615
-1% -$90K 0.68% 34
2014
Q3 		$6.02M Sell
112,079
-1,030
-0.9% -$54.6K 0.69% 38
2014
Q2 		$5.93M Buy
113,109
+3,895
+4% +$199K 0.65% 46
2014
Q1 		$5.77M Buy
109,214
+2,585
+2% +$119K 0.69% 45
2013
Q4 		$4.27M Sell
106,629
-5,000
-4% -$197K 0.53% 94
2013
Q3 		$4.22M Buy
111,629
+1,164
+1% +$45.4K 0.55% 85
2013
Q2 		$4.33M Buy
+110,465
New +$4.3M 0.62% 60

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Meritage Portfolio Management's TEVA Position: Q3 2017 in Review

Meritage Portfolio Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2017, closing a stake of 78,470 shares — an estimated $2.61M sold.

Meritage Portfolio Management first reported a position in TEVA in Q2 2013 and held it in 15 quarters. The position peaked at $7.17M in Q4 2015. 537 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.

  • Meritage Portfolio Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2017 after selling out during the quarter.
  • Meritage Portfolio Management sold 78,470 Teva Pharmaceutical Industries Limited shares in Q3 2017, an estimated $2.61M.
  • Meritage Portfolio Management first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and held it in 15 quarters.
  • Meritage Portfolio Management's Teva Pharmaceutical Industries Limited position peaked at $7.17M in Q4 2015.
  • 537 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2017.

Based on Meritage Portfolio Management's 13F filing for Q3 2017, filed 16 Oct 2017.